Hypercholesterolemia in children

Pediatric Annals

Volumn 26, Issue 2, 1997, Pages 122-127

  Carter, G A ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CHOLESTEROL; CHYLOMICRON; CLOFIBRATE; COLESTIPOL; COLESTYRAMINE; DEXTROTHYROXINE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PROBUCOL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DIET THERAPY; DYSLIPOPROTEINEMIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; MASS SCREENING; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031422967     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/0090-4481-19970201-12     Document Type: Review

References (29)

1. Enos WF, Holmes RH, Beyer J. Coronary disease among United States soldiers killed in action in Korea. JAMA. 1953;152:1090-1093.
2. Keys A, et al. Coronary heart disease in seven countries: summary. Circulation. 1970;41(suppl I):I-186-95.
3. Castelli WP. Epidemiology of coronary heart disease. The Framingham study. Am J Med. 1984;76:4-12.
4. Martin MJ, Hulley SB, Browner WS, Kuller L II, Wentworth D. Serum cholesterol, blood pressure and mortality implications from a cohort of 361,662 men. Lancet. 1986;ii:933-936.
5. Stamler J, Wentworth D, Neaton J. Is the relationship between serum cholesterol and the risk of death from coronary heart disease continuous and graded? Findings on the 356,222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
6. Lipid Research Clinics Program. The Lipid Research Clinic's coronary primary prevention trial results, II: the relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365-374.
7. Newman WP III, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa Heart Study. N Engl J Med. 1986;314:138-144.
8. PDAY Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. JAMA. 1990;264:3018-3024.
9. American Academy of Pediatrics Committee on Nutrition. Indications for cholesterol testing in children. Pediatrics. 1989;83:141-142.
10. Meyerson DA, Santanello NC. Pediatric lipid screening based upon criteria of high-risk family history fails to identify two-thirds of higher-risk children. Circulation. 1988;78(suppl 2):2-383.
11. Dennison BA, Kikuchi DA, Srinivasan SR, Webber LS, Berenson GS. Serum total cholesterol screening for the detection of elevated low-density lipoprotein in children and adolescents: the Bogalusa Heart Study. Pediatrics. 1990;85:472-479.
12. National Cholesterol Education Program. Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(suppl):525-584.
13. Kwiterovich PO. Diagnosis and management of familial dyslipoproteinemia in children and adolescents. Pediatr Clin North Am. 1990;37:1489-1523.
14. Rodriguez CR, Seman LJ, Ordvas JM, et al. Lipoprotein(a) and coronary heart disease. Chem Phys Lipids. 1994;67/68:389-398.
15. Gagliano NJ, Emans SJ, Woods ER. Cholesterol screening in the adolescent. J Adolesc Health. 1993;14:104-108.
16. Resnicow K, Cross D. Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines. Pediatrics. 1993;82:347-353.
17. Wadowski SJ, Karp RJ, Murray-Bachmann R, Senft C. Family history of coronary artery disease and cholesterol: screening children in a disadvantaged inner-city population. Pediatrics. 1994;93:109-113.
18. Primrose ED, Savage JM, Boreham CA, Cran GW, Strain JJ. Cholesterol screening and family history of vascular disease. Arch Dis Child. 1994;71:239-242.
19. Dennison BA, Jenkins PL, Pearson TA. Challenges to implementing the current Pediatric Cholesterol Screening Guidelines into practice. Pediatrics. 1994;94:296-302.
20. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Am J Epidemiol. 1991;133:884-899.
21. Lauer RM, Clark WR. Use of cholesterol measurements in childhood for the prediction of adult hypercholesterolemia: the Muscatine Study. JAMA. 1990;264:3034-3038.
22. ESPGAN Committee on Nutrition. Committee report: childhood diet and prevention of coronary heart disease. J Pediatr Gastroenterol Nutr. 1994;19:261-269.
23. The Dietary Intervention Study in Children. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol. JAMA. 1995;273:1429-1435.
24. Polonsky SM, Bellet PS, Sprecher DL. Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment. Pediatrics. 1993;91:92-96.
25. Kwiterovich PO. The role of fiber in the treatment of hypercholesterolemia in children and adolescents. Pediatrics. 1995;96(suppl):1005-1009.
26. Widhalm K, Brazda G, Schneider B, Kohl S. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia. J Pediatr. 1993;123:30-34.
27. Colletti RB, Neufeld EJ, Roff NK, McAuliffe TL, Baker AL, Newberger JW. Niacin treatment of hypercholesterolemia in children. Pediatrics. 1993;92:78-82.
28. Sinzinger H, Schmid P, Pirich C, Virgolini I, Pesau B, Granegger S, O'Grady J. Treatment of hypercholesterolemia in children. Lancet. 1992;340:548-549.
29. Ducobu J, Brasseur D, Chaudron JM, et al. Simvastatin use in children. Lancet. 1992;339:1488.